Hadassah

Hadassah Research Leads to Patent for Diabetes-Related Oral Delivery Technology

Thursday, Jan 22 2015

Oramed Pharmaceuticals Inc., focused on the development of oral drug delivery systems including an oral insulin pill based on Hadassah Medical Organization research, has received a patent from the Israel Patent Office for its invention, “Methods and Compositions for Oral Administrations of Exenatide.”

Eexenatide, a glucagon-like peptide-1 (GLP-1) analog, is a hormone which induces insulin release at increased glucose levels and causes a feeling of satiety, resulting in reduced food intake and weight loss. Currently, it is only marketed in injectable form. Oramed’s oral GLP-1 capsule, according to Oramed, could significantly increase compliance and become a valuable tool in the treatment of diabetes.

Oramed was founded in 2006 by Dr. Miriam Kidron, a senior researcher in the Diabetes Unit at Hadassah, who continues to serve as the company’s chief scientist. A pharmacologist and biochemist, Dr. Kidron earned her PhD in biochemistry from the Hadassah-Hebrew University and earned the Bern Schlanger Award for her work in diabetes research. Formerly a visiting professor at the Medical School at the University of Toronto, she is a member of the American, European, and Israeli diabetes associations.

Oramed's Protein Oral Delivery (PODTM) technology is based on over 30 years of research by top scientists at Hadassah. Oramed is seeking to revolutionize the treatment of diabetes through its proprietary flagship product, an orally ingestible insulin capsule (ORMD-0801). Having completed separate Phase IIa clinical trials, the company anticipates the initiation of separate Phase IIb clinical trials, in patients with both type 1 and type 2 diabetes, under an Investigational New Drug application with the United States Food and Drug Administration.

Read more

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Thursday, Jul 11 2019

Breakthrough at Hadassah Hospital in Correcting Scoliosis for Special-Needs Teen

Spine specialists at Hadassah Hospital Ein Kerem used an innovative, minimally invasive approach to correct scoliosis in a 14-year-old with Down syndrome.

READ MORE ›
alt_text

Thursday, Jul 11 2019

Hadassah Doctors Give a Gazan Patient With an Incurable Skin Disease a “Normal Life”

Pioneering treatment by physicians at Hadassah Hospital Ein Kerem is giving a Gazan man who suffers from...

READ MORE ›
alt_text

Tuesday, Jul 2 2019

“Just Clownin’ Around!” Medical Clown at Hadassah Hospital Turns Tears Into Laughter

Clowns aren't just at circuses anymore! At Hadassah Hospital in Jerusalem, clowns, working as part of the medical team, bring smiles to the faces of sick patients—children and adults alike—every day.

READ MORE ›
alt_text

Tuesday, Jul 2 2019

The School That Helps You Forget Your Cancer

With her eyes sparkling with excitement, five-year-old Osher Tubiyan said goodbye to Hadassah's hospitalized children’s school after eight months of successfully struggling with leukemia.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More